Shares of IQVIA Holdings Inc. IQV slid 2.81% to $148.99 Friday, on what proved to be an all-around grim trading session for ...

Q1 2025 Earnings Call Transcript May 6, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $2.7, ...

Shares of IQVIA Holdings Inc. rose 4.86% to $153.30 Wednesday, on what proved to be an all-around positive trading session ...

IQVIA Holdings (NYSE:IQV) recently reported their Q1 earnings with a beat on normalized EPS and revenue despite the challenges of navigating a very cautious healthcare sector. IQV has been one of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Bank of America Annual Health Care Conference on ...

IQVIA Holdings Inc. reported its first-quarter 2025 earnings, showcasing a robust financial performance with adjusted earnings per share (EPS) of $2.70, surpassing the forecast of $2.64.

The clinical testing company posted revenue of $3.83 billion in the period, which also beat Street forecasts. Nine analysts surveyed by Zacks expected $3.77 billion. IQVIA expects full-year earnings ...

This was the stock's second consecutive day of losses.

Ari Bousbib; Chairman of the Board, Chief Executive Officer; IQVIA Holdings Inc Ronald Bruehlman; Chief Financial Officer, Executive Vice President; IQVIA Holdings Inc Thank you for standing by.